Conceptus
About Conceptus News and Events Investors Careers
  Company History
Conceptus, Inc. was founded in late 1992 and began development of micro-catheter and guidewire systems that allowed physicians to access and navigate the fallopian tubes using a non-incisional approach.

While this technology was first used in products to diagnose or treat infertility, in 1998 the company focused on the design, development, and clinical testing of the Essure procedure, a non-incisional alternative to tubal ligation. The Essure product showed promise by eliminating the cutting, clipping, and burning associated with tubal ligation.

A trained gynecologist performs the Essure procedure. It does not require incisions or general anesthesia. A soft, flexible micro-insert is placed into each fallopian tube using the body's natural pathways.

Over the next three months, the woman's body and the micro-insert work together to form a tissue barrier within the fallopian tube that prevents sperm from reaching the egg.

Clinical testing demonstrated Essure to be 99.80% effective in preventing pregnancy, and 92% of women rated their long-term comfort with Essure as "good" to "excellent" at four years of follow-up.

Clinical testing also showed that recovery after the procedure was quick. In the Essure Pivotal Trial, 92% of women employed outside the home went back to work 24 hours or less after the day of the procedure. Indeed, many women said they resumed normal activities the very same day they had the procedure.

After clinical testing, Conceptus began marketing Essure commercially in Australia, Singapore, Europe, and Canada.

In November 2002, the U.S. Food and Drug Administration granted approval to market the Essure procedure in the United States. With this approval, Conceptus has access to a market of 700,000 tubal ligations and 400,000 vasectomies annually.

Conceptus completed its initial public offering (IPO) in February 1996 on the NASDAQ national stock market and is traded under the ticker symbol "CPTS".


   
  Site Index | Contact Us | Privacy | Product Sites